Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Daewoong showed improved performance both sales and earnings in Q1

prnasiaMay 08, 2021

Tag: Daewoong , ETC , OTC , Fexuprazan

PharmaSources Customer Service